CCChangjun Chen

Changjun Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Changjun Chen has a total of 140 co-authors. Here are the top co-authors by number of shared publications:

  • Pengde Kang

    Department of Orthopedic Surgery, West China Hospital, Sichuan University, Chengdu, China

    15 shared publications
  • Xin Zhao

    Department of Orthopedic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China

    9 shared publications
  • Yun Yang

    Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Jinan

    6 shared publications
  • Lei Zhang

    Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Tissue Engineering Laboratory, Department of Radiology, Shandong First Medical University, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Jinan, 250014, China

    5 shared publications
  • Qiuru Wang

    Department of Orthopedic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, People’s Republic of China

    5 shared publications
  • Qiuru Wang

    Department of Orthopedic Surgery, West China Hospital, Sichuan University, Chengdu, China

    5 shared publications

Latest Publications

  • Open Access

    Response to "Interpreting Route, Dose, and Clinical Relevance in Perioperative Magnesium Sulfate After Total Knee Arthroplasty” [Response to Letter]

    by Qiuru Wang, Yinchan Wang, Jian Hu, Changjun Chen, Jing Yang, Pengde Kang

    Response to Letter in regards to Interpreting Route, Dose, and Clinical Relevance in Perioperative Magnesium Sulfate After Total Knee Arthroplasty [Letter]

  • Open Access

    Effects of an Ultrasound‑Guided Femoral, Sciatic, and Genitofemoral Nerve Block with Ropivacaine on EC50 and EC95 for High Saphenous Vein Ligation

    by Hui Wang, Jiangtao Chang, Yufei Li, Lina Chen, Changjun Chen, Qiuru Wang, Xiaojun Gao, Fan Yang, Songsong Chen, Yuelan Wang, et al.

    Purpose: To determine the effective concentrations (EC50 and EC95) of ropivacaine for an ultrasound-guided triple nerve block (femoral(FNB), suprapopliteal sciatic(SPSB), and genitofemoral nerve femoral branch(GFNfB)) in patients undergoing high saphenous vein ligation and stripping. Methods: Thirty-six patients scheduled for elective unilateral high saphenous vein ligation and stripping were enrolled. Nerve blocks were performed under ultrasound guidance. The effective concentration of ropivacaine was determined using the Dixon–Massey up-and-down sequential allocation method (initial concentration: 0.25%; step size: 0.01%). EC50 and EC95 with 95% confidence intervals (CIs) were calculated using probit analysis. Hemodynamic parameters (systolic blood pressure(SBP), diastolic blood pressure(DBP), heart rate (HR)) were recorded at four time points. Pain intensity (visual analog scale, VAS) and motor block (modified Bromage score) were assessed at skin incision. Postoperative complications were recorded. Results: Relative to baseline, hemodynamic parameters showed small but statistically significant decreases at 15 and 30 minutes after block (all P < 0.05), remaining within clinically acceptable limits. At skin incision, the VAS score in the Success group (n = 23) was significantly lower than in the Failure group (n = 13) [median (IQR), 1 (0, 2) vs 5 (4, 5); z = − 5.000, P < 0.001], and the modified Bromage score was significantly higher [1 (0, 1) vs 0 (0, 0); z = − 3.062, P = 0.002]. The EC50 of ropivacaine was 0.149% (95% CI, 0.118– 0.165%) and the EC95 was 0.210% (95% CI, 0.181– 0.509%). No patient experienced local anesthetic systemic toxicity or other complications. Conclusion: This ultrasound-guided triple nerve block regimen is safe and effective for high saphenous vein ligation. The EC50 and EC95 of ropivacaine were 0.149% and 0.210%, respectively. An initial concentration of approximately 0.22% is suggested, with subsequent adjustment guided by individual response.

  • Open Access

    Effects of Combined Intravenous and Topical Magnesium Sulfate Administration on Pain, Stress, and Functional Recovery After Total Knee Arthroplasty: A Prospective, Randomized, Blinded Controlled Trial

    by Qiuru Wang, Yinchan Wang, Jian Hu, Changjun Chen, Jing Yang, Pengde Kang

    Purpose: Evidence suggests that both intravenous and intraoperative topical application of magnesium sulfate can improve pain management after total knee arthroplasty (TKA). However, the optimal method of magnesium sulfate administration remains unclear, and no studies have evaluated the effect of combined intravenous and topical application on post-TKA pain management. This study aimed to assess the effects of combined intravenous and topical magnesium sulfate on pain, stress, and functional recovery following TKA. Methods: In this randomized controlled trial, 150 patients undergoing TKA were randomly assigned to one of three groups: the Intravenous Group (received intravenous magnesium sulfate intraoperatively), the Topical Group (received magnesium sulfate added to the local infiltration analgesic cocktail), and the Combined Group (received both intravenous and topical magnesium sulfate). The primary outcome was the resting pain score at 24 hours postoperatively. Secondary outcomes included pain scores at other time points, postoperative morphine consumption for rescue analgesia, postoperative knee range of motion, walking ability, hospital length of stay, intraoperative stress levels (intraoperative inhaled anesthetic consumption, incidence of intraoperative hypertension), postoperative stress levels (postoperative serum cortisol/ACTH levels), and complication rates. Results: No significant difference was found in the resting Visual Analogue Scale (VAS) pain scores at 24 hours postoperatively among the three groups. Compared to the Intravenous and Topical groups, the Combined Group showed significantly lower VAS scores at several time points on the day of surgery, although this did not reach the minimal clinically important difference. No significant differences were observed among the three groups for the other secondary outcomes. Conclusion: Compared with intravenous or topical magnesium sulfate alone, combined intravenous and topical administration did not demonstrate a clinically significant advantage in postoperative pain management, stress response, or functional recovery. Further studies are warranted to determine the optimal route and regimen for perioperative magnesium sulfate administration in TKA.


  • Open Access

    Coral-inspired immunoreprogramming scaffold reverses the “immune-freeze” microenvironment to promote bone regeneration in steroid-induced osteonecrosis of the femoral head

    by Yue Luo, Qianhao Li, Changjun Chen, Xin Zhao, Zhouyuan Yang, Donghai Li, Ke Jiang, Yan Xiong, Meng Tian, Pengde Kang

    The core pathological mechanism of steroid-induced osteonecrosis of the femoral head (SONFH) is an “immune freeze” microenvironment—where corticosteroids continuously drive macrophages toward a pro-inflammatory M1 phenotype, inhibiting the conversion to reparative M2 macrophages, thereby impairing bone regeneration. To address this bottleneck, this study was inspired by the hierarchical pore structure of coral. Using low-temperature deposition 3D printing technology, we constructed an immunoreprogramming biomimetic scaffold that integrates multi-walled carbon nanotubes (MWCNT) and nano-hydroxyapatite (nHA) (MWCNT bionic scaffold). The scaffold leverages the active immune regulatory function of MWCNT to activate the PI3K-AKT signaling pathway, driving macrophages to transition from the M1 to M2 phenotype, effectively breaking the “immunological freeze” state and reshaping the pro-regenerative bone immune microenvironment. Meanwhile, the nHA component provides a biomimetic mineralization matrix and sustained release of calcium and phosphate ions, synergizing with the nanofiber structure of MWCNT to promote the migration and osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) and angiogenesis. In vivo experiments confirm that scaffold implantation reverses the local “immune freeze” state, drives macrophage polarization toward the M2 phenotype, reduces inflammatory responses, and enhances the maturation and functional vascular network formation of new bone matrix in bone defect areas, ultimately achieving bone structural reconstruction. The coral-inspired immunoreprogramming strategy proposed in this study provides a new strategy for targeting the regulation of the pathological microenvironment in SONFH.


  • Open Access

    Implementing Evidence‐Based, Phase‐Specific Multimodal Analgesia for Total Joint Arthroplasty: An Interprofessional Review for Nursing Practice and Management

    by Qiuru Wang, Dongmei Zhao, Jian Hu, Changjun Chen, Ting Ma, Xiaoyan Liu, Jing Yang, Pengde Kang

    Purpose: This review aims to synthesize current evidence on perioperative multimodal analgesia within enhanced recovery after surgery (ERAS) pathways for total joint arthroplasty (TJA). The primary objective is to translate this evidence into clear, actionable insights for nursing management and interprofessional collaboration, emphasizing the pivotal role of nursing professionals in orchestrating patient‐centered pain management to optimize outcomes. Methods: A structured narrative review was conducted to provide a clinically relevant synthesis of current evidence on perioperative multimodal analgesia within ERAS pathways for TJA. The review methodology was informed by established recommendations for rigorous narrative reviews, including the SANRA framework. PubMed and MEDLINE were searched for English‐language publications available up to June 2025. Studies were screened for relevance and prioritized according to methodological quality, clinical significance, and implications for nursing management and interprofessional practice, with particular emphasis on randomized controlled trials, cohort studies, clinical practice guidelines, systematic reviews, meta‐analyses, and landmark studies. Results: Multimodal analgesia, which synergistically combines pharmacologic and nonpharmacologic techniques, is the standard of care for TJA. Evidence supports phase‐specific protocols: preemptively, combining analgesics (e.g., COX‐2 inhibitors) 24–48 h preoperatively and tailoring regimens to patient risk profiles (e.g., duloxetine for central sensitization); intraoperatively, using local infiltration analgesia (LIA) as a cornerstone technique; and postoperatively, implementing a structured, nursing‐led “non‐opioid‐first” strategy with scheduled NSAIDs/acetaminophen and monitored opioid rescue protocols. For total knee arthroplasty (TKA), the combination of adductor canal block (ACB), IPACK block, and LIA is an evidence‐based strategy for optimizing analgesia while preserving motor function. Intravenous glucocorticoids are also recommended during surgery. Successful implementation is critically dependent on nursing management, including proactive patient education and expectation management, vigilant interpretive pain assessment, systematic monitoring for medication‐specific adverse effects, and coordination of mobilization with analgesic peaks. The heterogeneity of evidence underscores the need for standardized, institution‐specific protocols, implementation tools, and governance frameworks to support nursing‐led ERAS practice. Ultimately, effective analgesia functions within an interprofessional collaborative framework, in which nurses act as central coordinators facilitating communication among surgeons, anesthesiologists, and therapists to dynamically personalize care. Conclusions: The evolution toward personalized multimodal analgesia elevates the nursing role from protocol administration to essential clinical decision‐making and care coordination. Nursing leadership is indispensable for bridging evidence‐to‐practice gaps, minimizing practice variation, and ensuring patient safety. Key to success is the adoption of standardized pathways that empower nurses to lead patient education, assessment, and cross‐disciplinary communication. Future efforts should focus not only on refining analgesic evidence but also on implementation science, protocol governance, workforce competency development, and quality improvement strategies that facilitate sustainable integration into nursing workflows and consistently achieve superior analgesia, enhanced functional recovery, and minimized complications within ERAS programs.

  • Open Access

    Selenium Attenuates Dexamethasone‐Induced Osteoblast Dysfunction and Prevents Femoral Head Osteonecrosis via PI3K / AKT / GSK3β Pathway Activation

    by Sun Xuecheng, Chen Changjun, Ma Xiaojie, Li Shufeng, Zhang Lei, Xinlong Ma

    Objective: Glucocorticoid‐induced osteonecrosis of the femoral head (GC‐ONFH) represents a devastating complication of steroid therapy, primarily driven by osteoblast apoptosis and impaired osteogenesis. Although selenium (Se) is renowned for its potent bone‐protective properties, its therapeutic potential, and specific mechanisms in GC‐ONFH remain largely unexplored and thus require further investigation. Methods: To assess the therapeutic effectiveness of oral selenium supplementation in GC‐ONFH, a rat model of GC‐ONFH was utilized. The rats were randomly allocated into three groups ( n = 6 per group): (1) Control group, (2) Methylprednisolone sodium succinate (MPS) group, and (3) Se group. The intervention was carried out for 4 weeks. In vitro experiments utilized primary rat osteoblasts and MC3T3‐E1 cells to elucidate the mechanisms through which selenium mitigates dexamethasone (DEX)‐induced alterations in cell proliferation, apoptosis, and osteogenic differentiation. The assessments were conducted using micro‐CT and histomorphometry, CCK‐8 assays and flow cytometry, as well as RT–qPCR, Western blotting, and immunofluorescence. Results: Selenium supplementation effectively prevented trabecular collapse and significantly reduced the number of empty lacunae in rats with GC‐ONFH. Specifically, an optimal dose of 10 μmol Se successfully reversed the damage induced by DEX, including the restoration of cell proliferation, suppression of apoptosis, and rescue of osteogenic activity. Mechanistically, Se counteracts the DEX‐induced suppression of phosphorylated phosphatidylinositol 3‐kinase (p‐PI3K), phosphorylated protein kinase B (p‐AKT), and phosphorylated glycogen synthase kinase 3β (GSK3β) (p‐GSK3β), thereby activating the PI3K/AKT/GSK3β signaling pathway, which promotes cell proliferation, inhibits apoptosis, and enhances osteogenesis in osteoblasts. Conclusion: Selenium can activate the PI3K/AKT/GSK3β pathway, reverse DEX‐induced hypoproliferation and apoptosis, restore osteogenic capacity, prevent trabecular collapse, and attenuate GC‐ONFH in rat models. Our findings demonstrate that selenium supplementation can be regarded as a clinically applicable strategy for impeding the progression of GC‐ONFH in at‐risk patients.


  • [Mechanism of 4-methylcatechol in inhibiting fibroblast-like synoviocyte migration and suppressing inflammatory responses in treatment of rheumatoid arthritis].

    by Zhendong Ying, Peng Wang, Lei Zhang, Dailing Chen, Qiuru Wang, Qibin Liu, Tiantian Tang, Changjun Chen, Qingwei Ma

    To investigate the effects of 4-methylcatechol (4MC) on the migration and inflammatory response in rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS), as well as its underlying mechanisms of action. RA-FLS was isolated from synovial tissue donated by RA patients, and the optimal concentration of 4MC was determined by cell counting kit 8 method for subsequent experiments, and the effect of 4MC on the migratory ability of RA-FLS was evaluated via a cell scratch assay. An inflammation model of RA-FLS was induced by tumor necrosis factor α (TNF-α). Real-time fluorescence quantitative PCR and ELISA were employed to detect the gene and protein expression levels of interleukin-1β (IL-1β) and IL-6 in RA-FLS and their culture supernatants, respectively, thereby investigating the anti-inflammatory effects of 4MC. Western blot was used to examine the expressions of nuclear factor κB (NF-κB) signaling pathway-related proteins, including inhibitor of NF-κB-α (IKBα), phosphorylated (P)-IκBα, NF-κB-inducing kinase α (IKKα), P-IKKαβ, P-p65, and p65. Cellular immunofluorescence was utilized to detect the expression and localization of p65 in RA-FLS, exploring whether 4MC exerts its anti-inflammatory effects by regulating the NF-κB signaling pathway. Finally, a collagen-induced arthritis (CIA) mouse model was established. The anti-RA effect of 4MC in vivo was evaluated by gross observation and histological examination. 4MC inhibited RA-FLS migration in a concentration-dependent manner. In the TNF-α-induced RA-FLS inflammation model, 4MC significantly decreased the gene and protein expression levels of IL-1β and IL-6. Furthermore, 4MC markedly reduced the ratios of P-IΚBα/IΚBα, P-IKKαβ/IKKα, and P-p65/p65, thereby blocking the transcriptional activity of p65 by inhibiting its nuclear translocation. This mechanism effectively suppressed the activation of the TNF-α-mediated NF-κB signaling pathway. Animal studies demonstrated that 4MC [10 mg/(kg·day)] significantly lowered serum levels of IL-1β, IL-6, and TNF-α, and alleviated arthritis severity and bone destruction in CIA mice. 4MC not only inhibits the migration of RA-FLS but also mitigates their inflammatory response by suppressing the NF-κB signaling pathway, thereby effectively exerting its anti-RA effects.